🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT03283046
Treatments Being Tested
A phase 3, randomized, open-label, parallel-controlled, multi-center study ...
Status
Completed
Location
Capital Medical University (CMU) - Beijing Chao-Yang Hospital
Start Date
2019-03-27
Trial ID
NCT03952091
Treatments Being Tested
This phase I/II clinical trial is studying the side effects and best dose o...
Status
Terminated
Location
Lucile Packard Children's Hospital Stanford University
Start Date
2010-03
Trial ID
NCT01088763
This study is being done to determine the efficacies of two preventative dr...
Status
Completed
Location
The Ohio State University Wexner Medical Center
Start Date
2007-06
Trial ID
NCT01474915
Treatments Being Tested
This phase II trial studies how well daratumumab, azacitidine, and dexameth...
Status
Terminated
Location
University of California, San Francisco
Start Date
2020-11-30
Trial ID
NCT04407442
Treatments Being Tested
This study will test how effective the drug, Carfilzomib, reduces progressi...
Status
Completed
Location
Birmingham VA Medical Center
Start Date
2014-04
Trial ID
NCT02047253
Treatments Being Tested
This research is being done to assess the effectiveness and safety of the c...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-02-14
Trial ID
NCT04119336
Treatments Being Tested
Our hypothesis is that treating relapsed or refractory multiple myeloma wit...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2014-02
Trial ID
NCT02030483
Treatments Being Tested